Perform Another (Advanced) Search

1.  Study Posting (2348) Trial #106358, Diabetes Mellitus, Type 2, New York, NY
...Phase 3, Open-Label, Parallel Group Study to Evaluate the Efficacy and Safety of Human Insulin Inhalation Powder (HIIP) Compared to Preprandial Injectable Insulin in Insulin-Naive Patients with Type 2 Diabetes Mellitus [H7U-MC-IDAU] The purpose of ...
View Page

2.  Study Posting (2348) Trial #94806, Diabetes Mellitus, Type 2, New York, NY
...Phase 3, Open-Label, Parallel Group Study to Evaluate the Efficacy and Safety of Human Insulin Inhalation Powder (HIIP) Compared to Preprandial Injectable Insulin in Insulin-Naive Patients with Type 2 Diabetes Mellitus [H7U-MC-IDAU] The purpose of ...
View Page

3.  Study Posting (2348) Trial #94808, Diabetes Mellitus, Type 2, New York, NY
...Mellitus, Type 2, New York, NY Assessing the DURAbility of Basal vs. Lispro Mix 25 Insulin Efficacy<BR><BR>The Durability of Twice-Daily Insulin Lispro Low Mixture <BR>Compared to Once-Daily Insulin Glargine when <BR> added to Existing ...
View Page

4.  Study Posting (4519) Trial #142549, Diabetes Mellitus, Type 2, Tampere, Finland
...Information A Study of the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Insulin Glargine in Insulin Naive Type 2 Diabetic Patients Inadequately Controlled With Metformin Plus Sulphonylurea. Status: No longer recruiting ...
View Page

5.  Study Posting (4519) Trial #150922, Diabetes Mellitus, Type 2, Harrisburg, NC
...Information A Study of the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Insulin Glargine in Insulin Naive Type 2 Diabetic Patients Inadequately Controlled With Metformin Plus Sulphonylurea. Status: No longer recruiting ...
View Page

6.  Study Posting (4519) Trial #152862, Diabetes Mellitus, Type 2, Trinity, FL
...Information A Study of the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Insulin Glargine in Insulin Naive Type 2 Diabetic Patients Inadequately Controlled With Metformin Plus Sulphonylurea. Status: No longer recruiting ...
View Page

7.  Study Posting (4519) Trial #150820, Diabetes Mellitus, Type 2, Phoenix, AZ
...Information A Study of the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Insulin Glargine in Insulin Naive Type 2 Diabetic Patients Inadequately Controlled With Metformin Plus Sulphonylurea. Status: No longer recruiting ...
View Page

8.  Study Posting (4519) Trial #149787, Diabetes Mellitus, Type 2, Trowbridge, United Kingdom
...Information A Study of the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Insulin Glargine in Insulin Naive Type 2 Diabetic Patients Inadequately Controlled With Metformin Plus Sulphonylurea. Status: No longer recruiting ...
View Page

9.  Study Posting (4519) Trial #149854, Diabetes Mellitus, Type 2, Dumfries, United Kingdom
...Information A Study of the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Insulin Glargine in Insulin Naive Type 2 Diabetic Patients Inadequately Controlled With Metformin Plus Sulphonylurea. Status: No longer recruiting ...
View Page

10.  Study Posting (4519) Trial #149725, Diabetes Mellitus, Type 2, Havirov, Czech Republic
...Information A Study of the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Insulin Glargine in Insulin Naive Type 2 Diabetic Patients Inadequately Controlled With Metformin Plus Sulphonylurea. Status: No longer recruiting ...
View Page

11.  Study Posting (4519) Trial #147322, Diabetes Mellitus, Type 2, Vancouver, BC, Canada
...Information A Study of the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Insulin Glargine in Insulin Naive Type 2 Diabetic Patients Inadequately Controlled With Metformin Plus Sulphonylurea. Status: No longer recruiting ...
View Page

12.  Study Posting (4519) Trial #153957, Diabetes Mellitus, Type 2, Sherbrooke, QC, Canada
...Information A Study of the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Insulin Glargine in Insulin Naive Type 2 Diabetic Patients Inadequately Controlled With Metformin Plus Sulphonylurea. Status: No longer recruiting ...
View Page

13.  Study Posting (4519) Trial #142587, Diabetes Mellitus, Type 2, Hamilton, ON, Canada
...Information A Study of the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Insulin Glargine in Insulin Naive Type 2 Diabetic Patients Inadequately Controlled With Metformin Plus Sulphonylurea. Status: No longer recruiting ...
View Page

14.  Study Posting (5234) Trial #158717, Diabetes Mellitus, Type 2, Miami, FL
...multinational, open labelled, 2 armed, parallel group, treat-to-target once daily treatment trial with insulin detemir versus insulin glargine, both in combination with metformin in subjects with type 2 diabetes. To compare the ...
View Page

15.  Study Posting (4519) Trial #148023, Diabetes Mellitus, Type 2, Santa Ana, CA
...Information A Study of the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Insulin Glargine in Insulin Naive Type 2 Diabetic Patients Inadequately Controlled With Metformin Plus Sulphonylurea. Status: No longer recruiting ...
View Page

16.  Study Posting (4519) Trial #157354, Diabetes Mellitus, Type 2, Nis, Serbia and Montenegro
...Information A Study of the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Insulin Glargine in Insulin Naive Type 2 Diabetic Patients Inadequately Controlled With Metformin Plus Sulphonylurea. Status: No longer recruiting ...
View Page

17.  Study Posting (4519) Trial #157361, Diabetes Mellitus, Type 2, Kragujevac, Serbia and Montenegro
...Information A Study of the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Insulin Glargine in Insulin Naive Type 2 Diabetic Patients Inadequately Controlled With Metformin Plus Sulphonylurea. Status: No longer recruiting ...
View Page

18.  Study Posting (4519) Trial #157174, Diabetes Mellitus, Type 2, Belgrade, Serbia and Montenegro
...Information A Study of the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Insulin Glargine in Insulin Naive Type 2 Diabetic Patients Inadequately Controlled With Metformin Plus Sulphonylurea. Status: No longer recruiting ...
View Page

19.  Study Posting (4519) Trial #157201, Diabetes Mellitus, Type 2, Seoul, Korea, Republic of
...Information A Study of the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Insulin Glargine in Insulin Naive Type 2 Diabetic Patients Inadequately Controlled With Metformin Plus Sulphonylurea. Status: No longer recruiting ...
View Page

20.  Study Posting (4519) Trial #157451, Diabetes Mellitus, Type 2, Icheon, Korea, Republic of
...Information A Study of the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Insulin Glargine in Insulin Naive Type 2 Diabetic Patients Inadequately Controlled With Metformin Plus Sulphonylurea. Status: No longer recruiting ...
View Page